Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers ...

The Cyclone® IKON is IBA’s high energy and high-capacity cyclotron which offers the largest energy spectrum for the production of PET and SPECT isotopes from 13 MeV to 30 MeV ...

Beyond 2027, Idorsia aims to continue the sales trajectory of QUVIVIQ with a stable OPEX, leading to higher sustainable profitability. This could benefit from additional income from new collaborations ...

SYNDEO Medical is highly differentiated in the marketplace by integrating everyday-use diagnostic and interventional products—typically procured separately—into custom-designed interventional ...

Oslo, 20 May 2025. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors.

The Global Alzheimer’s Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose Alzheimer’s disease. Fujirebio’s Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio ...

TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate credit rating to ...

Event: William Blair 45th Annual Growth Stock Conference Date: Tuesday, June 3, 2025 Time: 7:20 a.m. PST / 9:20 a.m. CST A live and archived webcast of the presentation will be available in the ...

TrialWire is the AI and algorithm-powered patient-recruitment and enrollment platform, purpose-built on Salesforce Health Cloud to guarantee best-in-class data and IP security.

This major step unlocks a new milestone payment of €26.5 million under our Licensing and Collaboration Agreement with Ipsen 2, due upon pricing and reimbursement of Iqirvo® (elafibranor) in three ...

The awards were granted under the Vaxart, Inc. 2024 Inducement Award Plan as an employment “inducement award” pursuant to Nasdaq Listing Rule 5635 (c) (4). The Inducement Award Plan is used ...

RxSight’s management is scheduled to participate in a fireside chat on Tuesday, May 27, 2025, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. A live and archived webcast of the presentation will ...